A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Cidara Therapeutics Inc.’s current trading price is -46.67% away from its 52-week high, while its distance from the 52-week low is 143.43%. The stock’s price range for this time frame has been between $0.46 and $2.10. The trading volume of the company’s shares in the Healthcare reached around 0.89 million for the day, which was evidently higher than the average daily volume of 0.64 million over the last three months.
Cidara Therapeutics Inc. (CDTX) currently has a stock price of $1.12. The stock saw a sharp increase in the last trading session, hitting a high of $1.14 after opening at $0.99. The lowest recorded price for the day was $0.9875 before it closed at $0.99.
Cidara Therapeutics Inc.’s stock market performance has been consistent. The 1-year high for the company’s stock was recorded at $2.10 on 03/22/23, with the lowest value being $0.46 on 12/08/22.
How Financial Performance Impacts Market Capitalization
Cidara Therapeutics Inc. (CDTX) has experienced a quarterly decline of -6.67% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 100.39M and boasts a workforce of 73 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.0758, with a change in price of +0.0600. Similarly, Cidara Therapeutics Inc. recorded 854,882 in trading volume during the last 100 days, posting a change of +5.66%.
How CDTX’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for CDTX stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
CDTX Stock Stochastic Average
Cidara Therapeutics Inc.’s raw stochastic average for the past 50 days is currently at 86.21%. This represents a fall from the raw stochastic average of the last 20 days, which was recorded at 94.94%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 83.29% and 80.97%, respectively.
CDTX Stock Price Performance Analysis
The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. Year to date metric has recorded a gain of 48.09%.However, over the last six months, we can see a stronger performance of -34.12%. Over the last 30 days, the price of CDTX has fallen by 22.22%. And in the last five days, it has surged by 12.00%.